PRIA, Government Policy, Made Personal

Summary

Within 90 days after December 18, 2025, the Director of National Intelligence must create a policy, after talking with other intelligence leaders as needed, to stop parts of the intelligence community that buy products made with synthetic DNA or RNA from using certain Chinese biotech suppliers or U.S. biotech firms controlled by China that the Director says are security or supply risks. The policy must forbid buying those products unless the final assembly and all major processing happen in the United States and almost all parts and ingredients are made and sourced in the United States or an allied country. The Director can allow a waiver process so an agency head can get an exception if they follow any conditions set. Definitions: biotechnology = using biological systems for manufacturing, research, or medicine; Chinese biotechnology supplier = a biotech firm under China’s laws or control; Chinese biotechnology supply chain intermediary = a U.S. biotech firm controlled by China; synthetic DNA or RNA = nucleic acids made newly by chemical or enzyme methods.

Title 50, §3334e–1

War and National Defense, Source: USLM XML via OLRC

(a)Not later than 90 days after December 18, 2025, the Director of National Intelligence, in consultation with such other heads of elements of the intelligence community as the Director considers appropriate, shall establish a policy to ensure that elements of the intelligence community that procure products made using synthetic DNA or RNA from domestic sources do not contract with Chinese biotechnology suppliers or Chinese biotechnology supply chain intermediaries that are determined by the Director to pose a security or supply chain threat to the United States.

(b)The policy required by subsection (a) shall provide that an element of the intelligence community may not—

(1)procure or obtain any product made using synthetic DNA or RNA unless—

(A)the final assembly or processing of the product occurs in the United States;

(B)all significant processing of the product occurs in the United States; and

(C)all or nearly all ingredients or components of the product are made and sourced in the United States or an allied nation; or

(2)contract with any Chinese biotechnology supplier or Chinese biotechnology supply chain intermediary that is determined by the Director to pose a security or supply chain threat to the United States.

(c)As part of the policy required by subsection (a), the Director of National Intelligence may establish a waiver process for the heads of the elements of the intelligence community under which the head of the relevant element may waive the prohibition under subsection (b). A waiver may be made under the process only if the head of the relevant element complies with any conditions the Director may establish for the waiver process.

(d)In this section:

(1)The term “biotechnology” means the use of biological processes, organisms, or systems for manufacturing, research, or medical purposes, including genetic engineering, synthetic biology, and bioinformatics.

(2)The term “Chinese biotechnology supplier” means a supplier of biotechnology that is organized under the laws of, or otherwise subject to the jurisdiction of, the People’s Republic of China.

(3)The term “Chinese biotechnology supply chain intermediary” means a United States domestic supplier of biotechnology where a controlling interest in the United States domestic supplier is owned by the People’s Republic of China.

(4)The term “synthetic DNA or RNA” means any nucleic acid sequence that is produced de novo through chemical or enzymatic synthesis.

Statutory Notes and Related Subsidiaries

Definitions For definition of “intelligence community” as used in this section, see section 6002 of Pub. L. 119–60, set out as a note under section 3003 of this title.

§3334e–1 Ensuring Intelligence Community Procurement of Domestic United States Production of Synthetic Dna and Rna

Summary

Title 50, §3334e–1

Notes & Related Subsidiaries

Statutory Notes and Related Subsidiaries

Citations & Metadata